221 Crescent St
5th Floor
United States


Show jobs for this employer

About LumiraDx

LumiraDx is transforming community-based healthcare by providing fast, accurate and comprehensive diagnostic information at the point of need. The company’s innovative LumiraDx Platform is designed to perform a broad menu of tests including infectious and cardiovascular disease, diabetes and coagulation disorders, and deliver lab-comparable performance with results in 12 minutes. With its point of care platform, and Fast Lab Solutions, LumiraDx’s testing options support the diagnostic needs across settings;from the lab, to hospitals, the physician’s office, the workplace, and schools.  Founded in 2014, LumiraDx is based in the UK with R&D and manufacturing sites across the US and Europe.

Stock Symbol: LMDX

Stock Exchange: NASDAQ



LumiraDx transforming healthcare at the point of need

18 articles with LumiraDx